REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $611,000 | +8.1% | 3,917 | 0.0% | 0.04% | -11.6% |
| Q1 2020 | $565,000 | -29.5% | 3,917 | 0.0% | 0.04% | -6.5% |
| Q4 2019 | $801,000 | +155.1% | 3,917 | 0.0% | 0.05% | +130.0% |
| Q3 2019 | $314,000 | -15.1% | 3,917 | 0.0% | 0.02% | -20.0% |
| Q2 2019 | $370,000 | +10.4% | 3,917 | 0.0% | 0.02% | +19.0% |
| Q1 2019 | $335,000 | +52.3% | 3,917 | 0.0% | 0.02% | +31.2% |
| Q4 2018 | $220,000 | -31.2% | 3,917 | 0.0% | 0.02% | -30.4% |
| Q3 2018 | $320,000 | – | 3,917 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |